XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

XTalks

MARCH 25, 2021

Xtalks is proud to announce the launch of the Xtalks Life Science podcast. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Fresh Conversations About Life Science Topics. She focuses on news relating to the food industry and writes blogs on recruitment and HR in the life sciences.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.

Life Science 105

Life Science Gene Therapy DNA Vaccine 105

XTalks

SEPTEMBER 29, 2021

Life science workers are one of the most common areas of work that could not eliminate all visits to the office or lab during the COVID-19 pandemic. Additionally, these life science companies are now trying to find the new normal for many of their employees to accommodate the new lifestyle they have embraced.

Life Science 122

Life Science HR Scientist Genetic Disease 122

Pharmaceutical Technology

FEBRUARY 2, 2023

We are proud to have developed Jesduvroq as a new oral treatment where there is a patient desire for more options.” Last December, GSK and Wave Life Sciences entered a strategic partnership to drive the discovery and development of oligonucleotide therapies for new genetic targets.

FDA Approval 264

FDA Approval Life Science Genetics Trials 264

pharmaphorum

NOVEMBER 7, 2022

This month, we highlight new appointments from Lumeris, Lineage Cell Therapeutics, 1910 Genetics, and ADC Therapeutics. . ” Patrick Genestin, 1910 Genetics . “I am excited to join 1910 Genetics at such a pivotal time for the company,” Genestin said. Ben Grabski, Lumeris.

Life Science 105

Life Science Genetics Business Development Marketing 105

XTalks

NOVEMBER 26, 2024

BridgeBio has been highly active in the genetic diseases space. Its investigational therapy infigratinib recently received Breakthrough Therapy designation, becoming the first-ever potential treatment for achondroplasia — a genetic condition affecting bone growth — to achieve this milestone.

Genetic Disease 105

Genetic Disease Genetics Protein Clinical Development 105

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. The development and widespread adoption of new technologies is key to revolutionizing the way we diagnose, prevent, treat and manage disease. They can be developed and adapted quickly.

Life Science 98

Life Science RNA Vaccination Vaccine 98

XTalks

MAY 23, 2024

One of the more intriguing developments in cancer research in recent years is the growing understanding of clonal hematopoiesis, a phenomenon where blood cells expand from a single clone due to genetic mutations. Clonal hematopoiesis increases in prevalence with age and can precede hematologic malignancies.

Genetics 114

Genetics Research Genome Genomics 114

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Development Genetic Disease 225

XTalks

JANUARY 6, 2025

CF is a progressive genetic disease caused by defective CFTR proteins, which are crucial for regulating salt and water movement in cells. As a result, the diversity of CFTR mutations presents significant challenges in developing therapies that can benefit all CF patients.

Gene Therapy 105

Gene Therapy Protein Genetic Disease Gene 105

BioPharma Reporter

DECEMBER 16, 2022

GSK and genetic medicines company, Wave Life Sciences, have announced a strategic collaboration to advance oligonucleotide therapeutics across multiple disease areas.

Life Science 52

Life Science Genetics Development Medicine 52

Pharmaceutical Technology

FEBRUARY 13, 2023

Gene therapies are an attractive way of targeting the underlying genetic mutations, but traditional approaches cannot be used while targeting mutations for Dravet Syndrome, forcing researchers to develop new ways. To tackle this, companies have developed different ways to focus on the gene.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

FEBRUARY 4, 2025

Current Share Price: The announcement follows a $115 million Series D financing in December 2024, co-led by Frazier Life Sciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos Capital. MZE829 aims to mimic a protective genetic variant of APOL1. for an upfront payment of $150 million.

Clinical Trials 66

Clinical Trials Clinical Trials Trials Genetics 66

XTalks

SEPTEMBER 30, 2020

The two studies were recently published online in the journal Science, both of which were led by Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University. Casanova’s lab is now searching for the genetic driver behind the autoantibodies. Autoimmune Attack and COVID-19 Symptom Severity.

Antibody 135

Antibody Genetics Research In-Vitro 135

XTalks

MARCH 19, 2025

Elevidys is the first FDA-approved gene therapy for DMD a rare genetic disorder characterized by progressive muscle degeneration. Elevidys aims to address the underlying genetic cause by introducing a functional version of the dystrophin gene, which is essential for muscle function. Sarepta is reviewing all available data.

Gene Therapy 80

Gene Therapy Gene Genetics Clinical Trials 80

XTalks

APRIL 13, 2022

The editorial team also discussed a new rapid molecular test developed by UK-based Genedrive PLC that can help physicians select the best antibiotic to treat babies with to prevent hearing loss. Genedrive’s Genetic Test Can Prevent Hearing Loss in Babies Through Personalized Treatment.

Life Science 52

Life Science Genetics Research Development 52

Pharmaceutical Technology

JUNE 4, 2023

According to GlobalData, there are 60+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of transcription factors for AAV. Encoded Therapeutics develops gene therapies for the treatment of severe genetic disorders.

Gene 262

Gene Gene Therapy Genetics DNA 262

XTalks

MARCH 28, 2024

Duvyzat, a histone deacetylase (HDAC) inhibitor that works to reduce inflammation and muscle loss, is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD. According to the FDA, life expectancy for those with DMD has increased over the years, with some patients surviving beyond 30 years.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

XTalks

NOVEMBER 12, 2024

Studies also indicate that Gen-Xers and Millennials face a significantly higher risk of developing pancreatic and other cancers compared to previous generations. Key factors include: Family h istory: Having close relatives with pancreatic cancer or certain genetic mutations increases risk. percent compared to 18.6

Research 105

Research FDA Approval Trials Clinical Trials 105

STAT News

SEPTEMBER 12, 2022

In the life sciences industry, where company names derived from “biology” or “genetics” are a dime a dozen, it helps to have a brand that stands out. The company is developing treatments for diseases caused by broken mitochondria — the main energy source for human cells.

Genetic Disease 98

Genetic Disease Life Science Genetics Branding 98

XTalks

FEBRUARY 24, 2023

When life sciences industry partners with patients and their advocacy communities, the patient voice becomes integrated into the drug development process. However, as with any change, it is gradual, and there is certainly more work to be done in partnership with the patient communities served by these development programs.

Development 98

Development Clinical Trials Clinical Trials Gene Therapy 98

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. Inactive viruses often act as the viral vector, as they’re able to deliver genetic therapies efficiently.

Genome 105

Genome Genomics Medicine Development 105

XTalks

AUGUST 7, 2024

Lawreen is a seasoned biotech and life science professional with over 25 years of experience. Lawreen is dedicated to raising awareness about rare diseases like Usher syndrome, supporting and advocating for the USH patient community, and sharing research progress in the hopes of accelerating the development of more treatment options.

Life Science 52

Life Science Scientist Production Research 52

XTalks

SEPTEMBER 22, 2022

can act on existing genetic mutations to trigger inflammation and the development of cancer. Ayesha also talked about how a woman with a unique ability to smell Parkinson’s disease has helped scientists develop a new test that may aid in the early diagnosis of the condition. micrometers (PM2.5)

Life Science 52

Life Science Scientist Development Genetics 52

Pharmaceutical Technology

MAY 22, 2023

The new good manufacturing practices facility was established with support from the Singapore Economic Development Board. It comes with quick vaccine fill-finish capabilities and offers end-to-end pharmaceutical development and manufacturing services.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccine 147

Pharmaceutical Technology

JANUARY 12, 2023

Solid Biosciences has entered a strategic research collaboration with Phlox Therapeutics to expedite the development of new therapies for rare cardiac diseases. Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM).

RNA 130

RNA Gene Therapy Genetics Genetic Disease 130

XTalks

SEPTEMBER 27, 2023

Poseida is a clinical-stage biopharmaceutical firm that utilizes its unique non-viral gene engineering methods to develop innovative cell and gene therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Scientists working at Poseida Therapeutics.

Life Science 59

Life Science Genetic Engineering Engineer Gene Therapy 59

XTalks

DECEMBER 9, 2024

This initiative is particularly impactful for rare diseases and genetic disorders, where traditional endpoints may be infeasible. Programs like the Rare Disease Endpoint Advancement Pilot encourage collaboration with the FDA to establish novel surrogate endpoints.

Clinical Trials 105

Clinical Trials Clinical Trials Compliance Trials 105

Intouch Solutions

MARCH 18, 2025

The POV highlights the multifaceted nature of health determinants, noting that while genetics play a role, many other factors such as social, economic, and environmental elements are equally important. These determinants are crucial for engaging with digital health tools and services, which can significantly impact health outcomes.

Life Science 59

Life Science Genetics Development Marketing 59

XTalks

DECEMBER 4, 2024

CAMP4’s RNA-based therapies focus on genetic diseases like urea cycle disorders, while Rapport’s small molecules aim to address epilepsy, pain and bipolar disorder. Jupiter joins a wave of biotech IPOs this year, stepping into a competitive space while broadening treatment options for CNS patients.

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. So, we set out to solve some of the problems,” she explains.

Genome 244

Genome Genomics Medicine Gene Therapy 244

pharmaphorum

OCTOBER 2, 2020

Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to take its shares public. The post $110m financing sets up US, Asia expansion for Sophia Genetics appeared first on.

Genetics 59

Genetics Genome Genomics Life Science 59

XTalks

OCTOBER 22, 2024

Recruitment and Selection of Participants Obesity affects people across different ages, ethnicities and socioeconomic backgrounds, each with distinct genetic, environmental and behavioral factors contributing to their condition. This diversity requires flexible and inclusive recruitment strategies that can engage a broad participant base.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

FEBRUARY 21, 2025

Current Share Price: PWS is a complex, genetically determined neurodevelopmental disorder that affects multiple organ systems. And hyperphagia is common not only to PWS but also to hypothalamic obesity, binge-eating disorder and certain rare genetic disorders like Bardet-Biedl syndrome.

Genetics 59

Genetics Hormones Gene Expression Gene 59

XTalks

NOVEMBER 14, 2024

This therapy, the first of its kind to be administered directly into the brain, addresses a rare genetic disorder that severely affects motor function and dopamine production. Symptoms of AADC deficiency, such as delays in motor skills like sitting, standing and muscle control, often appear in infancy, limiting development.

Gene Therapy 105

Gene Therapy FDA Approval Gene Clinical Trials 105

XTalks

APRIL 15, 2021

Experts from Servier and Genuity Science recently spoke on a webinar about using genomics data to drive drug development in heart failure and identify new targets for novel therapeutics. The reverse could also be true whereby the development of coronary artery disease may impact heart rate. HFrEF vs. HFpEF.

Development 98

Development Drugs Genome Genomics 98